Short answer: the safest way to buy BPC-157 in Canada is from a supplier that ships from inside the country and gives you a batch-specific Certificate of Analysis. Your order never crosses a border, so there is no CBSA hold, no brokerage fee and no seized parcel. Below is everything else you need: what BPC-157 is, what the published research has studied, how to spot a fake, and what you should be paying per milligram.
What is BPC-157?
BPC-157 (Body Protection Compound 157) is a synthetic peptide made of 15 amino acids:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
It is a fragment of a larger protein found in human gastric juice, which is why you will often see it called a stable gastric pentadecapeptide. Its molecular weight is about 1419.5 Da. That number matters later, because it is the figure a real mass spectrometry test should confirm.
Two properties made BPC-157 interesting to researchers. First, it is unusually stable: unlike most peptides, it survives gastric acid in lab conditions. Second, it shows activity across very different tissue types in preclinical models, from tendon to gut lining. That breadth is why it has become the most searched research peptide in Canada.
| Sequence length | 15 amino acids |
|---|---|
| Molecular weight | ~1419.5 Da |
| Origin | Fragment of a human gastric protein (synthetic) |
| Common vial sizes | 2 mg, 5 mg, 10 mg (lyophilized powder) |
| Storage (powder) | −20 °C long term, 2–8 °C short term, away from light |
| Reconstitution | Bacteriostatic water |
What the research has studied
Most BPC-157 literature comes from Professor Predrag Sikirić’s group at the University of Zagreb, with independent work from groups in Taiwan and elsewhere. Almost all of it is preclinical: cell cultures and animal models. Here are the main research threads.
1. Tendon and ligament models
This is the thread most Canadians searching for BPC-157 care about. In a 2011 study in the Journal of Applied Physiology, Chang and colleagues reported that BPC-157 promoted tendon explant outgrowth, cell survival and tenocyte migration in vitro. Earlier rat work examined Achilles tendon-to-bone detachment (Krivic et al., 2006) and medial collateral ligament transection (Cerovecki et al., 2010), with treated groups showing better healing scores than controls.
Why tendons? They have very poor blood supply, so they heal slowly. Which leads to the second thread.
2. Angiogenesis and the VEGFR2 pathway
Several studies link BPC-157 to new blood-vessel formation. A 2017 paper by Hsieh and colleagues in the Journal of Molecular Medicine associated its pro-angiogenic activity with activation and up-regulation of VEGFR2, a key receptor in vessel growth. In tissue that is starved of blood flow, that mechanism is the bottleneck researchers want to study.
3. Nitric oxide signalling
BPC-157 has repeatedly been examined for its interaction with the nitric oxide (NO) system, which regulates blood vessel tone and tissue homeostasis. Many of the Zagreb group’s models test it alongside NO-blocking and NO-boosting agents to map that relationship.
4. Gut lining models
Given where it comes from, BPC-157 was first studied in gastrointestinal models: lesions, fistulas and inflammation in rodents. Sikirić’s 2011 review in Current Pharmaceutical Design summarizes this foundational work.
The honest caveat: almost none of this has been replicated in large human trials. The published evidence is strong enough to keep labs interested, and nowhere near strong enough to call BPC-157 a proven treatment for anything. Anyone telling you otherwise is selling hype.
5 BPC-157 myths, answered honestly
Myth 1: “BPC-157 is proven to heal injuries in humans.”
Not proven. The tendon, ligament and gut data come overwhelmingly from animal and cell models. Human data is limited to small, uncontrolled reports. That is the gap between “promising” and “proven.”
Myth 2: “All BPC-157 is the same.”
BPC-157 is one of the most faked peptides on the market because it is cheap to sell and impossible to check by eye. Under-dosed vials, wrong peptides and powder with no identity test are common. Only a batch-specific COA tells you what is actually in the vial.
Myth 3: “Oral and injectable BPC-157 are interchangeable.”
They are different research formats. The stability that makes BPC-157 interesting in gastric models does not mean every format behaves the same way in every model. Research protocols specify a format for a reason.
Myth 4: “BPC-157 is banned in Canada.”
It is not a controlled substance in Canada. It is also not approved by Health Canada for any human use. Those two facts sit side by side, and the next section explains what that means.
Myth 5: “Cheaper overseas BPC-157 is just as good.”
Sometimes it is cheaper per vial. But imported parcels can sit in customs for weeks, get seized outright, and spend days in uncontrolled temperatures. With no COA matched to your lot, you cannot tell whether that cheaper vial survived the trip.
Is BPC-157 legal in Canada?
BPC-157 is not a scheduled controlled substance in Canada, and it is not approved by Health Canada as a drug or natural health product. In practice, that means it is sold in Canada as a research chemical, labelled for laboratory use only and not for human or veterinary use.
A few related facts worth knowing:
- Health Canada has issued public advisories about unauthorized injectable peptide products marketed for human use.
- BPC-157 is on the World Anti-Doping Agency prohibited list, so it is banned in tested sport.
- In the United States, it is not FDA-approved. An FDA advisory committee voted in July 2026 to recommend allowing pharmacy compounding, but that non-binding vote still requires an FDA decision and rulemaking.
All TrueLabs compounds are supplied strictly for in vitro and laboratory research.
How to buy BPC-157 in Canada (and avoid fakes)
Every peptide shop looks the same online. Use this 5-point checklist before you order from anyone, including us.
- It ships from inside Canada. No border, no CBSA hold, no brokerage fee, and delivery in 2–4 business days instead of 2–6 weeks.
- The COA is batch-specific. A generic “sample COA” proves nothing. The lot number on the certificate should match the lot number on your vial.
- It tests identity, not just purity. HPLC shows how pure the sample is. Mass spectrometry (MS or LC-MS) confirms it is actually BPC-157, with a mass near 1419.5 Da. You want both.
- The lab is independent. A COA issued by the seller’s own manufacturer is a marketing document. Look for a third-party lab name you can check.
- Prices are in CAD with a real Canadian contact. USD pricing and no Canadian address usually means a reseller shipping from abroad.
Red flags
- Purity claims of “99.9%+” with no document behind them
- The same COA image used for every batch
- Prices far below the rest of the market
- Sites that promise human results, cures or dosing “protocols”
BPC-157 price in Canada: what you should pay
The fair way to compare suppliers is price per milligram, not price per vial. Across Canadian domestic suppliers in 2026, research-grade BPC-157 generally falls in a range of roughly $5 to $11 per mg, with bigger vials costing less per mg.
TrueLabs BPC-157 starts at $22.00 for 2 mg during the current batch pre-order (30% off). Orders over $200 ship free anywhere in Canada.
Lyophilized BPC-157 needs bacteriostatic water for reconstitution in the lab. Pharmacies often do not stock it, so add a vial to the same order.
BPC-157 vs TB-500: which one do researchers use?
They get compared constantly, but it is the wrong comparison. They work through mechanisms that do not overlap.
| BPC-157 | TB-500 | |
|---|---|---|
| Origin | Gastric protein fragment | Derived from thymosin beta-4 |
| Size | 15 amino acids | Short active region of a 43-aa protein |
| Main research mechanism | Angiogenesis, VEGFR2, nitric oxide | Actin regulation, cell migration |
| Most studied tissues | Tendon, ligament, gut | Connective tissue, cardiac, wound models |
Because one addresses blood supply and the other cell movement, many research designs study them together. That is the logic behind the BPC-157 + TB-500 blend, often nicknamed the “Wolverine” combination. If your protocol needs a different ratio, buy BPC-157 and TB-500 as separate vials.
Want the full side-by-side? Read BPC-157 vs TB-500: roads vs trucks, and learn how to read a peptide COA before you buy anywhere.
Frequently asked questions
Cliquez sur une question pour afficher la réponse.
Is BPC-157 legal in Canada?
BPC-157 is not approved by Health Canada as a drug or natural health product. It is sold in Canada as a research chemical for laboratory use only, labelled not for human or veterinary use.
Where can I buy BPC-157 in Canada?
From a supplier that ships from inside Canada and publishes a batch-specific Certificate of Analysis. TrueLabs ships BPC-157 domestically, with tracked delivery in 2–4 business days and no customs.
How much does BPC-157 cost in Canada?
Roughly $5 to $11 per mg depending on vial size. Larger vials lower the price per mg.
How should BPC-157 powder be stored?
Lyophilized powder keeps best at −20 °C long term and 2–8 °C short term, protected from light and moisture. Avoid repeated freeze-thaw cycles.
How do I know my BPC-157 is real?
Check for a batch-specific COA showing HPLC purity plus mass spectrometry identity with a molecular weight near 1419.5 Da, from an independent lab, matching the lot number on your vial.
What is the difference between BPC-157 and TB-500?
BPC-157 is studied mainly for angiogenesis and nitric oxide signalling. TB-500 is studied for actin regulation and cell migration. Their mechanisms do not overlap, which is why they are often studied together.
Selected research references
- Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612–1632. PubMed
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774–780. PubMed
- Krivic A, Anic T, Seiwerth S, Huljev D, Sikiric P. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation. J Orthop Res. 2006;24(5):982–989. PubMed
- Cerovecki T, Bojanic I, Brcic L, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155–1161. PubMed
- Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med. 2017. PubMed
Related: How long does BPC-157 take to work?
All TrueLabs products are sold for in vitro and laboratory research use only. They are not intended for human or veterinary use, and nothing in this article is medical advice or a recommendation to use any compound. If you are dealing with an injury or a health concern, please talk to a doctor or physiotherapist.